The biological significance of brain barrier mechanisms: Help or hindrance in drug delivery to the central nervous system?

F1000Research

Volumn 5, Issue , 2016, Pages

  Saunders, Norman R ^a   Habgood, Mark D ^a   Møllgård, Kjeld ^b   Dziegielewska, Katarzyna M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BRAIN BARRIER; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; CHOROID PLEXUS; DRUG RESEARCH; HIGH THROUGHPUT SCREENING; HUMAN; MULTIPLE SCLEROSIS; NEUROMODULATION; NONHUMAN; PREGNANT WOMAN; REVIEW; SIGNAL TRANSDUCTION; TANYCYTE; TRANSCYTOSIS; TRANSPORT KINETICS;

EID: 84964612022     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.7378.1     Document Type: Review

References (129)

1. Krogh A: The active and passive exchanges of inorganic ions through the surfaces of living cells and through living membranes generally. Proc R Soc Lond B. 1946;133(871):140-200. 21014293 10.1098/rspb.1946.0008
2. Saunders NR Dreifuss JJ Dziegielewska KM: The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history. Front Neurosci. 2014;8:404. 25565938 10.3389/fnins.2014.00404 4267212
3. Stern L Gautier R: Recherches sur le liquide céphalo-rachidien. 1. Les rapports entre le liquide céphalo-rachidien et la circulation sanguine. Arch Int Physiol. 1921;17(2):138-192. 10.3109/13813452109146211
4. Ehrlich P: Das Sauerstoffbedürfnis des Organismus. Eine Farbenanalytische Studie.Berlin: Hirschwald;1885. Reference Source
5. Lewandowsky M: Zur Lehre von der Cerebrospinalflüssgkeit. Z Clin Med. 1900;40:480-494.
6. Goldmann EE: Die äussere und innere Sekretion des gesunden und kranken Organismus im Lichte der 'vitalen Färbung.1909.
7. Mäe M Armulik A Betsholtz C: Getting to know the cast - cellular interactions and signaling at the neurovascular unit. Curr Pharm Des. 2011;17(26):2750-2754. 21827409 10.2174/138161211797440113
8. Sá-Pereira I Brites D Brito MA: Neurovascular unit: a focus on pericytes. Mol Neurobiol. 2012;45(2):327-347. 22371274 10.1007/s12035-012-8244-2
9. Alvarez JI Saint-Laurent O Godschalk A: Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions. Neurobiol Dis. 2015;74:14-24. 25448765 10.1016/j.nbd.2014.09.016
10. Liddelow S Barres B: SnapShot: Astrocytes in Health and Disease. Cell. 2015;162(5):1170-1170.e1. 26317476 10.1016/j.cell.2015.08.029
11. Brightman MW Reese TS: Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol. 1969;40(3):648-677. 5765759 10.1083/jcb.40.3.648 2107650
12. Nabeshima S Reese TS Landis DM: Junctions in the meninges and marginal glia. J Comp Neurol. 1975;164(2):127-169. 810497 10.1002/cne.901640202
13. Brøchner CB Holst CB Møllgård K: Outer brain barriers in rat and human development. Front Neurosci. 2015;9:75. 25852456 10.3389/fnins.2015.00075 4360706
14. Engelhardt B Sorokin L: The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol. 2009;31(4):497-511. 19779720 10.1007/s00281-009-0177-0
15. Daneman R Zhou L Kebede AA: Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010;468(7323):562-566. 20944625 10.1038/nature09513 3241506 F1000 Recommendation
16. Errede M Girolamo F Rizzi M: The contribution of CXCL12-expressing radial glia cells to neuro-vascular patterning during human cerebral cortex development. Front Neurosci. 2014;8:324. 25360079 10.3389/fnins.2014.00324 4197642
17. Caley DW Maxwell DS: Development of the blood vessels and extracellular spaces during postnatal maturation of rat cerebral cortex. J Comp Neurol. 1970;138(1):31-47. 5412719 10.1002/cne.901380104
18. Neuwelt EA: Mechanisms of disease: the blood-brain barrier. Neurosurgery. 2004;54(1):131-40- discussion 141-2. 14683550 10.1227/01.NEU.0000097715.11966.8E
19. Krish B Leonhardt H: The functional and structural border of the neurohemal region of the median eminence. Cell Tissue Res. 1978;192(2):327-339. 359161 10.1007/BF00220750
20. Price CJ Hoyda TD Ferguson AV: The area postrema: a brain monitor and integrator of systemic autonomic state. Neuroscientist. 2008;14(2):182-194. 18079557 10.1177/1073858407311100
21. Møllgård K Balslev Y Lauritzen B: Cell junctions and membrane specializations in the ventricular zone (germinal matrix) of the developing sheep brain: a CSF-brain barrier. J Neurocytol. 1987;16(4):433-444. 3681347 10.1007/BF01668498
22. Fossan G Cavanagh ME Evans CA: CSF-brain permeability in the immature sheep fetus: a CSF-brain barrier. Brain Res. 1985;350(1-2):113-124. 3986606 10.1016/0165-3806(85)90255-X
23. Whish S Dziegielewska KM Møllgård K: The inner CSF-brain barrier: developmentally controlled access to the brain via intercellular junctions. Front Neurosci. 2015;9:16. 25729345 10.3389/fnins.2015.00016 4325900
24. Davson H Segal MB: Physiology of the CSF and Blood-Brain Barriers.Boca Raton: CRC Press;1996. Reference Source
25. Damkier HH Brown PD Praetorius J: Cerebrospinal fluid secretion by the choroid plexus. Physiol Rev. 2013;93(4):1847-1892. 24137023 10.1152/physrev.00004.2013
26. Liddelow SA Dziegielewska KM Ek CJ: Mechanisms that determine the internal environment of the developing brain: a transcriptomic, functional and ultrastructural approach. PLoS One. 2013;8(7):e65629. 23843944 10.1371/journal.pone.0065629 3699566
27. Oldendorf WH: Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol. 1971;221(6):1629-1639. 5124307
28. Daneman R Zhou L Agalliu D: The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS One. 2010;5(10):e13741. 21060791 10.1371/journal.pone.0013741 2966423 F1000 Recommendation
29. Shawahna R Uchida Y Declèves X: Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm. 2011;8(4):1332-1341. 21707071 10.1021/mp200129p F1000 Recommendation
30. Geier EG Chen EC Webb A: Profiling solute carrier transporters in the human blood-brain barrier. Clin Pharmacol Ther. 2013;94(6):636-639. 24013810 10.1038/clpt.2013.175 3906042 F1000 Recommendation
31. Marques F Sousa JC Coppola G: Transcriptome signature of the adult mouse choroid plexus. Fluids Barriers CNS. 2011;8(1):10. 21349147 10.1186/2045-8118-8-10 3042978 F1000 Recommendation
32. Ho HT Dahlin A Wang J: Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier. Front Pharmacol. 2012;3:154. 22936914 10.3389/fphar.2012.00154 3426838
33. Liddelow SA Temple S Møllgård K: Molecular characterisation of transport mechanisms at the developing mouse blood-CSF interface: a transcriptome approach. PLoS One. 2012;7(3):e33554. 22457777 10.1371/journal.pone.0033554 3310074
34. Saunders NR Daneman R Dziegielewska KM: Transporters of the blood-brain and blood-CSF interfaces in development and in the adult. Mol Aspects Med. 2013;34(2-3):742-752. 23506907 10.1016/j.mam.2012.11.006
35. Kratzer I Liddelow SA Saunders NR: Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection. Fluids Barriers CNS. 2013;10(1):25. 23915922 10.1186/2045-8118-10-25 3737068
36. Saunders NR Dziegielewska KM Møllgård K: Influx mechanisms in the embryonic and adult rat choroid plexus: a transcriptome study. Front Neurosci. 2015;9:123. 25972776 10.3389/fnins.2015.00123 4412010
37. Dean M Rzhetsky A Allikmets R: The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001;11(7):1156-1166. 11435397
38. Hartz AMS Bauer B: ABC transporters in the CNS - an inventory. Curr Pharm Biotechnol. 2011;12(4):656-673. 21118088 10.2174/138920111795164020
39. Strazielle N Ghersi-Egea JF: Efflux transporters in blood-brain interfaces of the developing brain. Front Neurosci. 2015;9:21. 25698917 10.3389/fnins.2015.00021 4318338
40. Ek CJ Wong A Liddelow SA: Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat. Toxicol Lett. 2010;197(1):51-59. 20466047 10.1016/j.toxlet.2010.04.025
41. Beaulieu E Demeule M Ghitescu L: P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem J. 1997;326(Pt 2):539-544. 9291129 10.1042/bj3260539 1218702
42. Bendayan R Lee G Bendayan M: Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc Res Tech. 2002;57(5):365-380. 12112443 10.1002/jemt.10090
43. Roberts LM Black DS Raman C: Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Neuroscience. 2008;155(2):423-438. 18619525 10.1016/j.neuroscience.2008.06.015 F1000 Recommendation
44. Cooray HC Blackmore CG Maskell L: Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport. 2002;13(16):2059-2063. 12438926 10.1097/00001756-200211150-00014 F1000 Recommendation
45. Daood M Tsai C Ahdab-Barmada M: ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics. 2008;39(4):211-218. 19165709 10.1055/s-0028-1103272 2821654
46. Bauer B Hartz AM Lucking JR: Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. J Cereb Blood Flow Metab. 2008;28(6):1222-1234. 18349876 10.1038/jcbfm.2008.16 F1000 Recommendation
47. Nies AT Jedlitschky G König J: Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience. 2004;129(2):349-360. 15501592 10.1016/j.neuroscience.2004.07.051 F1000 Recommendation
48. Gazzin S Strazielle N Schmitt C: Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J Comp Neurol. 2008;510(5):497-507. 18680196 10.1002/cne.21808 F1000 Recommendation
49. Maliepaard M Scheffer GL Faneyte IF: Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001;61(8):3458-3464. 11309308 F1000 Recommendation
50. Matsuoka Y Okazaki M Kitamura Y: Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain. J Neurobiol. 1999;39(3):383-392. 10363911 10.1002/(SICI)1097-4695(19990605)39:3<383::AID-NEU5>3.0.CO;2-4
51. Bougoin S Lomet D Kerboeuf D: Evidence that the choroids plexus in female sheep express P-glycoprotein. Neuro Endocrinol Lett. 2008;29(4):438-442. 18766153
52. Mercier C Masseguin C Roux F: Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes. Brain Res. 2004;1021(1):32-40. 15328029 10.1016/j.brainres.2004.06.034 F1000 Recommendation
53. Rao VV Dahlheimer JL Bardgett ME: Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci USA. 1999;96(7):3900-3905. 10097135 10.1073/pnas.96.7.3900 22392
54. Löscher W Potschka H: Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci. 2005;6(8):591-602. 16025095 10.1038/nrn1728
55. Higgins CF Gottesman MM: Is the multidrug transporter a flippase? Trends Biochem Sci. 1992;17(1):18-21. 1374941 10.1016/0968-0004(92)90419-A
56. Schumacher U Møllgård K: The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain. Histochem Cell Biol. 1997;108(2):179-182. 9272437 10.1007/s004180050159
57. Virgintino D Errede M Girolamo F: Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol. 2008;67(1):50-61. 18091560 10.1097/nen.0b013e31815f65d9 F1000 Recommendation
58. He Y Yao Y Tsirka SE: Cell-culture models of the blood-brain barrier. Stroke. 2014;45(8):2514-2526. 24938839 10.1161/STROKEAHA.114.005427 4668829 F1000 Recommendation
59. Patel MM Goyal BR Bhadada SV: Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs. 2009;23(1):35-58. 19062774 10.2165/0023210-200923010-00003 F1000 Recommendation
60. Lajoie JM Shusta EV: Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier. Annu Rev Pharmacol Toxicol. 2015;55:613-631. 25340933 10.1146/annurev-pharmtox-010814-124852 F1000 Recommendation
61. Palmiotti CA Prasad S Naik P: In vitro cerebrovascular modeling in the 21 st century: current and prospective technologies. Pharm Res. 2014;31(12):3229-3250. 25098812 10.1007/s11095-014-1464-6 4225221
62. Wilhelm I Krizbai IA: In vitro models of the blood-brain barrier for the study of drug delivery to the brain. Mol Pharm. 2014;11(7):1949-1963. 24641309 10.1021/mp500046f
63. Stanimirovic DB Bani-Yaghoub M Perkins M: Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics. Expert Opin Drug Discov. 2015;10(2):141-155. 25388782 10.1517/17460441.2015.974545
64. Wolff A Antfolk M Brodin B: In Vitro Blood-Brain Barrier Models-An Overview of Established Models and New Microfluidic Approaches. J Pharm Sci. 2015;104(9):2727-2746. 25630899 10.1002/jps.24329
65. Revest PA Jones HC Abbott NJ: Transendothelial electrical potential across pial vessels in anaesthetised rats: a study of ion permeability and transport at the blood-brain barrier. Brain Res. 1994;652(1):76-82. 7525022 10.1016/0006-8993(94)90319-0
66. Macdonald JA Murugesan N Pachter JS: Endothelial cell heterogeneity of blood-brain barrier gene expression along the cerebral microvasculature. J Neurosci Res. 2010;88(7):1457-1474. 20025060 10.1002/jnr.22316 F1000 Recommendation
67. Ohtsuki S Ikeda C Uchida Y: Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. Mol Pharm. 2013;10(1):289-296. 23137377 10.1021/mp3004308
68. Cotzias GC Papavasiliou PS Gellene R: Experimental treatment of parkinsonism with L-Dopa. Neurology. 1968;18(3):276-277. 4869717
69. Qosa H Miller DS Pasinelli P: Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders. Brain Res. 2015;1628(Pt B):298-316. 26187753 10.1016/j.brainres.2015.07.005 4681613
70. Grandjean P Landrigan PJ: Developmental neurotoxicity of industrial chemicals. Lancet. 2006;368(9553):2167-2178. 17174709 10.1016/S0140-6736(06)69665-7
71. Rapoport SI Hori M Klatzo I: Reversible osmotic opening of the blood-brain barrier. Science. 1971;173(4001):1026-1028. 5098961 10.1126/science.173.4001.1026
72. Brightman MW Hori M Rapoport SI: Osmotic opening of tight junctions in cerebral endothelium. J Comp Neurol. 1973;152(4):317-325. 4784295 10.1002/cne.901520402
73. Neuwelt EA Maravilla KR Frenkel EP: Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. J Clin Invest. 1979;64(2):684-688. 457877 10.1172/JCI109509 372166
74. Doolittle ND Muldoon LL Culp AY: Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances. Adv Pharmacol. 2014;71:203-243. 25307218 10.1016/bs.apha.2014.06.002 F1000 Recommendation
75. Bellavance MA Blanchette M Fortin D: Recent advances in blood-brain barrier disruption as a CNS delivery strategy. AAPS J. 2008;10(1):166-177. 18446517 10.1208/s12248-008-9018-7 2751463 F1000 Recommendation
76. Rodriguez A Tatter SB Debinski W: Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment. Pharmaceutics. 2015;7(3):175-187. 26247958 10.3390/pharmaceutics7030175 4588193
77. Bakay L: Development of the blood-brain barrier. In: Bakay L, editor. The blood brain barrier, with special regard to the use of radioactive isotopes. Springfield, IL: Charles C Thomas;1956;77-149.
78. Patrick JT Nolting MN Goss SA: Ultrasound and the blood-brain barrier. Adv Exp Med Biol. 1990;267:369-381. 2088054
79. Hynynen K McDannold N Vykhodtseva N: Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology. 2001;220(3):640-646. 11526261 10.1148/radiol.2202001804 F1000 Recommendation
80. Aryal M Vykhodtseva N Zhang YZ: Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study. J Control Release. 2015;204:60-69. 25724272 10.1016/j.jconrel.2015.02.033 4385501 F1000 Recommendation
81. Wei KC Tsai HC Lu YJ: Neuronavigation-guided focused ultrasound-induced blood-brain barrier opening: a preliminary study in swine. AJNR Am J Neuroradiol. 2013;34(1):115-120. 22723060 10.3174/ajnr.A3150 F1000 Recommendation
82. Burgess A Hynynen K: Noninvasive and targeted drug delivery to the brain using focused ultrasound. ACS Chem Neurosci. 2013;4(4):519-526. 23379618 10.1021/cn300191b 3629738
83. Timbie KF Mead BP Price RJ: Drug and gene delivery across the blood-brain barrier with focused ultrasound. J Control Release. 2015;219:61-75. 26362698 10.1016/j.jconrel.2015.08.059 4656107
84. Meairs S: Facilitation of Drug Transport across the Blood-Brain Barrier with Ultrasound and Microbubbles. Pharmaceutics. 2015;7(3):275-293. 26404357 10.3390/pharmaceutics7030275 4588200
85. Paul D Cowan AE Ge S: Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels. Microvasc Res. 2013;86:1-10. 23261753 10.1016/j.mvr.2012.12.001 3570614 F1000 Recommendation
86. Pardridge WM: Drug and gene targeting to the brain with molecular Trojan horses. Nat Rev Drug Discov. 2002;1(2):131-139. 12120094 10.1038/nrd725
87. Hindle SJ Bainton RJ: Barrier mechanisms in the Drosophila blood-brain barrier. Front Neurosci. 2014;8:414. 25565944 10.3389/fnins.2014.00414 4267209
88. Limmer S Weiler A Volkenhoff A: The Drosophila blood-brain barrier: development and function of a glial endothelium. Front Neurosci. 2014;8:365. 25452710 10.3389/fnins.2014.00365 4231875
89. Umans RA Taylor MR: Zebrafish as a model to study drug transporters at the blood-brain barrier. Clin Pharmacol Ther. 2012;92(5):567-570. 23047649 10.1038/clpt.2012.168
90. Fleming A Diekmann H Goldsmith P: Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish. PLoS One. 2013;8(10):e77548. 24147021 10.1371/journal.pone.0077548 3797749
91. Fardel O Le Vee M Jouan E: Nature and uses of fluorescent dyes for drug transporter studies. Expert Opin Drug Metab Toxicol. 2015;11(8):1233-1251. 26050735 10.1517/17425255.2015.1053462 F1000 Recommendation
92. Neuwelt EA Bauer B Fahlke C: Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci. 2011;12(3):169-182. 21331083 10.1038/nrn2995 3335275
93. Blanchette M Daneman R: Formation and maintenance of the BBB. Mech Dev. 2015;138(Pt 1):8-16. 26215350 10.1016/j.mod.2015.07.007
94. Marques F Sousa JC: The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system. Front Cell Neurosci. 2015;9:136. 26236190 10.3389/fncel.2015.00136 4394702
95. Stolp HB Dziegielewska KM: Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol. 2009;35(2):132-146. 19077110 10.1111/j.1365-2990.2008.01005.x
96. Brown PD Davies SL Speake T: Molecular mechanisms of cerebrospinal fluid production. Neuroscience. 2004;129(4):957-970. 15561411 10.1016/j.neuroscience.2004.07.003 1890044
97. Murphy VA Johanson CE: Acidosis, acetazolamide, and amiloride: effects on 22Na transfer across the blood-brain and blood-CSF barriers. J Neurochem. 1989;52(4):1058-1063. 2926388 10.1111/j.1471-4159.1989.tb01847.x
98. Damkier HH Nielsen S Praetorius J: Molecular expression of SLC4-derived Na +-dependent anion transporters in selected human tissues. Am J Physiol Regul Integr Comp Physiol. 2007;293(5):R2136-46. 17715183 10.1152/ajpregu.00356.2007
99. Pollay M Hisey B Reynolds E: Choroid plexus Na+/K+-activated adenosine triphosphatase and cerebrospinal fluid formation. Neurosurgery. 1985;17(5):768-772. 2999636
100. Johanson CE Duncan JA 3rd Klinge PM: Multiplicity of cerebrospinal fluid functions: New challenges in health and disease. Cerebrospinal Fluid Res. 2008;5:10. 18479516 10.1186/1743-8454-5-10 2412840
101. Oshio K Watanabe H Song Y: Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin-1. FASEB J. 2005;19(1):76-78. 15533949 10.1096/fj.04-1711fje
102. Owler BK Pitham T Wang D: Aquaporins: relevance to cerebrospinal fluid physiology and therapeutic potential in hydrocephalus. Cerebrospinal Fluid Res. 2010;7:15. 20860832 2949735
103. Amtorp O Sorensen SC: The ontogenetic development of concentration differences for protein and ions between plasma and cerebrospinal fluid in rabbits and rats. J Physiol. 1974;243(2):387-400. 4141371 10.1113/jphysiol.1974.sp010759 1330714
104. Johanson CE Murphy VA: Acetazolamide and insulin alter choroid plexus epithelial cell [Na+], pH, and volume. Am J Physiol. 1990;258(6 Pt 2):F1538-46. 2193541
105. Bass NH Lundborg P: Postnatal development of bulk flow in the cerebrospinal fluid system of the albino rat: clearance of carboxyl-( 14C)inulin after intrathecal infusion. Brain Res. 1973;52:323-332. 4739806 10.1016/0006-8993(73)90668-9
106. Johanson CE Woodbury DM: Changes in CSF flow and extracellular space in the developing rat. In " Drugs and the developing brain." Vernadakis A, Weiner N, editors. New York: Plenum;1974;281-287. 10.1007/978-1-4684-3063-9_15
107. Johanson CE Reed DJ Woodbury DM: Developmental studies of the compartmentalization of water and electrolytes in the choroid plexus of the neonatal rat brain. Brain Res. 1976;116(1):35-48. 974769 10.1016/0006-8993(76)90247-X
108. Pardridge WM: Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959-1972. 22929442 10.1038/jcbfm.2012.126 3494002
109. Liang Y Li S Chen L: The physiological role of drug transporters. Protein Cell. 2015;6(5):334-350. 25797421 10.1007/s13238-015-0148-2 4417677
110. Bauer B Hartz AM Fricker G: Modulation of p-glycoprotein transport function at the blood-brain barrier. Exp Biol Med (Maywood). 2005;230(2):118-127. 15673560
111. Kantorovich S Astary GW King MA: Influence of neuropathology on convection-enhanced delivery in the rat hippocampus. PLoS One. 2013;8(11):e80606. 24260433 10.1371/journal.pone.0080606 3832660
112. Abbott NJ: Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis. 2013;36(3):437-449. 23609350 10.1007/s10545-013-9608-0
113. Gherardini L Bardi G Gennaro M: Novel siRNA delivery strategy: a new "strand" in CNS translational medicine? Cell Mol Life Sci. 2014;71(1):1-20. 23508806 10.1007/s00018-013-1310-8
114. Yarnitsky D Gross Y Lorian A: Blood-brain barrier opened by stimulation of the parasympathetic sphenopalatine ganglion: a new method for macromolecule delivery to the brain. J Neurosurg. 2004;101(2):303-309. 15309923 10.3171/jns.2004.101.2.0303
115. Yarnitsky D Gross Y Lorian A: Increased BBB permeability by parasympathetic sphenopalatine ganglion stimulation in dogs. Brain Res. 2004;1018(2):236-240. 15276883 10.1016/j.brainres.2004.05.103
116. Dereymaeker A Gonsette R: An experimental permeabilization of the blood-brain barrier by electric field application. Eur Neurol. 1977;15(6):333-339. 902668 10.1159/000114822
117. Saunders NR Liddelow SA Dziegielewska KM: Barrier mechanisms in the developing brain. Front Pharmacol. 2012;3:46. 22479246 10.3389/fphar.2012.00046 3314990
118. Frömter E Diamond J: Route of passive ion permeation in epithelia. Nat New Biol. 1972;235(53):9-13. 4502409 10.1038/newbio235009a0
119. Ek CJ Dziegielewska KM Stolp H: Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum ( Monodelphis domestica). J Comp Neurol. 2006;496(1):13-26. 16528724 10.1002/cne.20885 2634607
120. Krueger M Bechmann I Immig K: Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia. J Cereb Blood Flow Metab. 2015;35(2):292-303. 25425076 10.1038/jcbfm.2014.199 4426746
121. Knowland D Arac A Sekiguchi KJ: Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron. 2014;82(3):603-617. 24746419 10.1016/j.neuron.2014.03.003 4016169
122. Prasad S Sajja RK Naik P: Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview. J Pharmacovigil. 2014;2(2):125. 25632404 10.4172/2329-6887.1000125 4306190
123. Willyerd FA , Empey PE , Philbrick A: Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans. J Neurotrauma. 2016;33(2):226-231. 25891836 10.1089/neu.2015.3879 4722575
124. Saunders NR Dziegielewska KM Møllgård K: Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives? Front Neurosci. 2015;9:385. 26578854 10.3389/fnins.2015.00385 4624851
125. Iliff JJ Goldman SA Nedergaard M: Implications of the discovery of brain lymphatic pathways. Lancet Neurol. 2015;14(10):977-9. 26376966 10.1016/S1474-4422(15)00221-5 4655610
126. Korogod N Petersen CC Knott GW: Ultrastructural analysis of adult mouse neocortex comparing aldehyde perfusion with cryo fixation. eLife. 2015;4:e05793. 26259873 10.7554/eLife.05793 4530226 F1000 Recommendation
127. Hammarlund-Udenaes M Fridén M Syvänen S: On the rate and extent of drug delivery to the brain. Pharm Res. 2008;25(8):1737-1750. 18058202 10.1007/s11095-007-9502-2 2469271 F1000 Recommendation
128. de Lange EC Danhof M: Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet. 2002;41(10):691-703. 12162757 10.2165/00003088-200241100-00001
129. Louveau A Smirnov I Keyes TJ: Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337-341. 26030524 10.1038/nature14432 4506234